Phase 2 Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with cervical cancer confirmed by a laboratory tissue test, specifically one of these types: squamous cell carcinoma, adenocarcinoma, or adenosquamous carcinoma
- People whose cancer has been staged as FIGO stage IIB, III, or IVA (using the 2018 staging system), meaning the cancer has spread beyond the cervix but has not reached distant parts of the body
- People who have a measurable tumour visible on a pelvic MRI scan taken within the 30 days before treatment begins
- People aged 20 years or older
- People who are generally well enough to carry out daily activities with little or no limitation (known in medical terms as ECOG performance status 0–1; confirm with trial site if unsure how this applies)
- People whose blood test results show the bone marrow is producing enough blood cells — including white blood cells, infection-fighting cells (neutrophils), platelets, and red blood cells — at levels meeting the trial's minimum thresholds
- People whose kidneys are functioning well enough, as shown by a blood test measuring creatinine levels below a certain threshold
- People who are able to give written consent to participate in the trial
Who may not be able to join:
- People whose cancer has spread to distant parts of the body (distant metastasis)
- People who have previously had radiotherapy to the pelvic area
- People who have already received chemotherapy or combined chemotherapy and radiotherapy as a main treatment for their cervical cancer diagnosis
- People who have had surgery to treat their current cervical cancer
- People who had a cone biopsy or a procedure called LEEP (a type of electrical loop excision of cervical tissue) before starting radiotherapy
- People who are not well enough to receive combined chemotherapy and radiotherapy treatment
- People who have had another active cancer (other than certain low-risk cancers such as carcinoma in situ of the cervix, basal cell skin cancer, or superficial bladder cancer) within the past 3 years, or whose previous cancer came back within 3 years after treatment
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +82-10-9933-2616
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Tumor Volume Redution Rate (TVRR) at 1 month after completion of treatment based on MRI
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.